Fig. 2From: Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experienceKaplan-Meier analysis of major amputation-free survival rates after PBDSCs transplantation (a). Kaplan-Meier analysis of major amputation-free survival rates for the PCCs versus PBMNCs groups (b). PBDSCs, peripheral blood-derived stem cells; PCCs, purified CD34+ cells; PBMNCs, peripheral blood mononuclear cellsBack to article page